Ozembic

We are investigating cases involving individuals who have developed gastroparesis (stomach paralysis) after using the weight loss medication Ozempic. The manufacturer of this pharmaceutical did not provide adequate warnings to patients and healthcare providers about the risks of severe gastrointestinal side effects, such as gastroparesis.

Indications & Usage of Ozempic

Ozembic is a glucagon-like peptide-1 receptor agonists (GLP-1 RA) containing semaglutide. The FDA approved Ozembic in 2017 to control high blood sugar in individuals with type 2 diabetes. Ozempic is an injection, though other semaglutide-containing drugs may be taken orally. Ozempic treats type 2 diabetes at lower doses.

Scientific Studies

Recent studies have linked GLP-1 receptor agonists to delayed gastric emptying and gastroparesis, highlighting the serious risks associated with these medications.

What is Gastroparesis?

Gastroparesis is a condition where the stomach does not empty properly, leading to various digestive issues. Symptoms include nausea, vomiting, abdominal pain, bloating, and weight loss. There is no cure, and treatments offer only temporary relief.

Understanding the Lawsuits

National media has highlighted the issues faced by users of this diabetes medication, reporting that doctors are now documenting cases of gastroparesis among their patients. The FDA has also received reports of this condition in individuals taking GLP-1 Receptor Agonists, such as Ozempic.

The first lawsuit involved a woman who began Ozempic injections in 2022 and developed severe stomach paralysis within two years. Even after discontinuing Ozembic and switching to another medication, her symptoms persisted. Novo Nordisk, the manufacturer, failed to include warnings about the risk of gastroparesis with these drugs.

Potential Compensation

Compensation in these cases can vary based on the severity and type of injuries. Settlements typically cover:

- Past and future medical treatment costs, including surgeries

- Past and future medical expenses

- Past and future lost income

- Pain and suffering from injuries, treatment, and recovery

- Loss of enjoyment of life

- Loss of earning capacity

- Potential punitive damages

We will work to ensure you receive the maximum financial compensation for your injuries caused by this medication.

Filing a Lawsuit

We are currently investigating cases for individuals who meet the following criteria:

- Diagnosed with gastroparesis, stomach paralysis, or gastric obstruction while taking Ozembic or within 30 days of stopping

- Required emergency room visits or hospital admissions

If you or a loved one meets developed gastroparesis, stomach paralysis or gastric obstruction while taking Ozembic, contact us for a free case evaluation and consultation.